NLS Medtech News

MedTech Business – November 12, 2026

First patient treated with RayStation reirradiation tools in Leeds

Leeds Cancer Centre has treated the first patient using new reirradiation functionality in RaySearch Laboratories’ RayStation treatment planning system. The tools were developed over more than a decade of collaboration with Leeds Teaching Hospitals NHS Trust and the University of Leeds.

Sponsored content

Build a Targeted Biomarker Strategy for Your Program

Turn biological signals into meaningful development insights with a biomarker strategy tailored to your program. 

Acquisition – October 28, 2026

SenzaGen acquires UK immunotoxicology firm Alcyomics

Swedish SenzaGen has agreed to acquire Alcyomics, a UK company that tests drug candidates for immune-related side effects without using animals. The initial price is approximately SEK 28 million, and the deal takes SenzaGen into safety testing of biological drugs such as antibodies and T-cell engagers.

Sponsored content

ViewLinc Cloud Suite supports life science innovation from laboratory to regulated operations

Vaisala introduces ViewLinc Cloud Suite, a cloud-based environmental monitoring solution that helps organizations start professional-quality monitoring immediately and scale as needs evolve, complemented by Vaisala Care for ViewLinc lifecycle services in selected markets.

Financing – October 27, 2026

Medistim posts record quarter, introduces quarterly dividend

Norwegian medtech company Medistim reported record third-quarter revenue of NOK 210.0 million, up 25.9% from NOK 166.8 million a year earlier. Operating profit rose 55.7% to NOK 63.1 million, and the board decided on the company’s first quarterly dividend, NOK 2.50 per share.

Profiles in MedTech

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.